References
- Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenia. Archives of General Psychiatry 1988; 45: 789–796
- Alvir J MJ, Lieberman J A, Safferman A Z, Schwimmer J L. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. New England Journal of Medicine 1993; 329: 162–167
- Frankenburg F R, Kando J. Eosinophilia, clozapine and pancreatitis. Lancet 1992; 340: 251
- Martin A. Acute pancreatitis associated with clozapine use. American Journal of Psychiatry 1992; 149: 714
- Friedberg J W, Frankenburg F R, Burk J, Johns- W. Clozapine-caused eosinophilic colitis. Annals of Clinical Psychiatry 1995; 7: 97–98
- Banov M D, Tohen M, Friedberg J. High risk of eosinophlia in women treated with clozapine. Journal of Clinical Psychiatry 1993; 54: 466–469
- Lader M. Experience with clozapine in the United Kingdom. Presented at the NIMH New Clinical Drug Evaluation Unit Program, 31st Annual Meeting, Key Biscayne, Florida, 28–31 May, 1991
- Tihonen J, Paanila J. Eosinophdia associated with clozapine. Lancet 1992; 399: 488
- Weller P F. The immmuno biology of eosinophilia. New England Journal of Medicine 1991; 324: 1110–1118
- Galletly C, Wilson D, McEwen S. Eosinophilia associated with decreasing neutrophil count in a clozapine-treated patient. Journal of Clinical Psychiatry 1995; 57(1)40–41
- Ames D, Carter J W, Wirshing W C, Marder S R, Goldstein M J. Clozapine associated eosinophilia and neutropenia. Schizophrenia Research 1995; 15: 141–142
- Fauci A S. The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic and therapeutic considerations. Annals of Internal Medicine 1982; 97: 78–92
- Hummer M, Sperner-Unterweger B, Kernrnler G. Does eosinophilia predict clozapine induced neutropenia. Psychophamocology 1996; 124: 201–204